PRESTIGE CONSUMER HEALTHCARE INC. Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax of $1.36 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax · last filed 2020-08-06
- PRESTIGE CONSUMER HEALTHCARE INC. other comprehensive income (loss), cash flow hedge, reclassification for discontinuance, before tax for the quarter ending 2020-06-30 was $1.36M.
- PRESTIGE CONSUMER HEALTHCARE INC. other comprehensive income (loss), cash flow hedge, reclassification for discontinuance, before tax for the quarter ending 2020-03-31 was $1.45M.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax 6 month |
|---|---|---|
| 2020-06-30 | $1.36M 10-Q · filed 2020-08-06 | $2.81M derived: sum of 2 quarters · filed 2020-08-06 |
| 2020-03-31 | $1.45M 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |